Gene · 6595
Papers3,459
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 3,459
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Retinal and Choriocapillaris Thickness and Age in Macaques in Development and Aging. | Invest Ophthalmol Vis Sci | 2026 | 41609174 | PubTator, text mining | PubMed |
| Neurogenesis and the Epigenetic Landscape: Role of Histone Modifications and Chromatin Remodeling. | Brain Behav | 2026 | 41601423 | PubTator, text mining | PubMed |
| SWI/SNF Chromatin Remodelling Complex in Hepatic Physiology: Mechanistic Insights Into Development, Homeostasis and Pathogenesis. | J Cell Mol Med | 2026 | 41578412 | PubTator, text mining | PubMed |
| Epigenetic mechanisms and therapeutic advances in diffuse midline glioma (Review). | Oncol Rep | 2026 | 41574724 | PubTator, text mining | PubMed |
| A novel dual histone mark reader ZCWPW2 regulates meiotic recombination through lactylation and transcriptional regulation in humans and mice. | Nucleic Acids Res | 2026 | 41574437 | PubTator, text mining | PubMed |
| Expanding the Phenotypic Spectrum Associated With Loss-of-Function SMARCA4 Variants to Eye Developmental Anomalies. | Clin Genet | 2026 | 41568967 | PubTator, text mining | PubMed |
| Highly effective combination of BRG1/BRM inhibitor with BET inhibitor or decitabine for high-risk MECOM-rearranged AML. | Hemasphere | 2026 | 41551728 | PubTator, text mining | PubMed |
| Analysis of SWI Complex Subunits in 69 Cases of TTF-1 Negative Non-Small Cell Lung Carcinoma. | Diagn Cytopathol | 2026 | 41549059 | PubTator, text mining | PubMed |
| Long non-coding RNA UCA1 modulates SMARCA2-containing SWI/SNF chromatin remodeling complexes in human colorectal cancer. | iScience | 2026 | 41537001 | PubTator, text mining | PubMed |
| Allosteric PROTACs: Expanding the Horizon of Targeted Protein Degradation. | J Am Chem Soc | 2026 | 41530095 | PubTator, text mining | PubMed |
| Molecular Mechanisms and Therapeutic Potential of Degron-Mediated Proteostasis Regulation in Neurodegenerative Diseases. | Cell Mol Neurobiol | 2026 | 41528540 | PubTator, text mining | PubMed |
| SWI/SNF complexes modulate gene expression and the development of physical dependence to ethanol. | Alcohol Clin Exp Res (Hoboken) | 2026 | 41527326 | PubTator, text mining | PubMed |
| Whole genome sequencing approach to assess homologous recombination deficiency in a pan-cancer cohort. | Commun Med (Lond) | 2026 | 41526458 | PubTator, text mining | PubMed |
| Bilateral congenital glaucoma in a child with Nicolaides-Baraitser syndrome: a case report. | Ann Med Surg (Lond) | 2026 | 41497020 | PubTator, text mining | PubMed |
| A Gold-PROTAC Degrades the Oncogenic Tyrosine Kinase MERTK: Insights into the Degradome from a Steady-State System. | ACS Chem Biol | 2026 | 41486557 | PubTator, text mining | PubMed |
| Conformation-Dependent Complexation Interactions for a SMARCA2 PROTAC and Cyclodextrin. | Mol Pharm | 2026 | 41420600 | PubTator, text mining | PubMed |
| Blended Phenotypes in Siblings: Dual Diagnoses of Nicolaides-Baraitser and Craniosynostosis Syndromes. | Mol Syndromol | 2026 | 41409309 | PubTator, text mining | PubMed |
| Successful Treatment With Neoadjuvant Chemo-Immunotherapy for Thoracic SMARCA4-Deficient Undifferentiated Tumor: A Patient Report and Literature Review. | Int J Surg Pathol | 2026 | 41364474 | PubTator, text mining | PubMed |
| PRT3789 Is a First-in-Human SMARCA2-Selective Degrader That Induces Synthetic Lethality in SMARCA4-Mutated Cancers. | Cancer Res | 2026 | 40991405 | PubTator, text mining | PubMed |
| Colorectal carcinoma with sarcomatoid component: isolated SMARCA2 loss and high PD-L1 expression as a potential therapeutic target. | Histopathology | 2026 | 40981612 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6595/papers?page=4